[An era of international collaboration in pediatric rheumatology]

Yosef Uziel1, Pinchas Hashkes

  • 1Pediatric Rheumatology, Department of Pediatrics, Meir Medical Center, Kfar Saba, Sackler Faculty of Medicine, Tel Aviv University, Israel. uziely@zahav.net.il

Harefuah
|October 27, 2011
PubMed

Insights

International collaboration in pediatric rheumatology research has grown significantly, enabling crucial studies on rare diseases. This has led to important findings in epidemiology, genetics, and treatment for pediatric rheumatic conditions.

Area of Science:

  • Pediatric Rheumatology
  • Rare Diseases
  • Multicenter Research

Context:

  • Pediatric rheumatologic diseases are rare, necessitating collaborative research efforts.
  • Meaningful research requires large patient cohorts, achievable through multicenter studies.
  • Global collaboration has expanded significantly in pediatric rheumatology over the past two decades.

Purpose:

  • To describe the evolution of international collaboration in pediatric rheumatology.
  • To highlight key research findings from major international studies.
  • To underscore the importance of multicenter research for rare pediatric diseases.

Summary:

  • International collaboration has transformed pediatric rheumatology research, moving from isolated efforts to a global network of hundreds of centers.
  • This collaborative approach facilitates the enrollment of adequate patient numbers for comprehensive studies on disease epidemiology, diagnostic criteria, genetics, pathogenesis, outcomes, and treatment.
  • Significant research advancements have been achieved through major international studies focusing on prevalent pediatric rheumatic conditions.

Impact:

  • Enabled large-scale epidemiological studies for rare pediatric rheumatic diseases.
  • Facilitated the development of standardized diagnostic and classification criteria.
  • Advanced understanding of genetic predispositions, disease pathogenesis, and treatment protocols.
  • Improved patient outcomes through evidence-based treatment strategies derived from international research.

Related Concept Videos

Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...